PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2014 2015 2016 2017
NOTE: The following is taken from summaries released by PEPFAR on the PEPFAR Data Dashboard. They are incomplete summary paragraphs only and do not contain the full mechanism details. When the full narratives are released, we will update the mechanism pages accordingly.
PQM will help assure to the quality and safety of priority essential medicines in Indonesia by strengthening the capacity of the MOH’s Food and Drug Administration to test and monitor the quality of post-production medicines, and better manage the growing challenge posed by substandard and counterfeit medicines. As the MOH implements a policy for Strategic Use of ARV (SUFA) for a selected 75 districts over the next three years, it is crucial to ensure that the medicines for HIV and Opportunistic Infections, from the central warehouse (national level) to district level health facilities, maintain a consistent high quality that is verified throughout the supply chain. This effort builds on similar work funded by USAID’s TB program.
US Pharmacopeia will work with health facilities and warehouses at selected districts in Jakarta, East Java, North Sumatra, Papua and West Papua to ensure the medicines stored at their facilities are of high quality. PQM will convene routine multi-stakeholder meetings and continue to foster public-private partnerships.
Activities to improve the drug quality in Indonesia will, in turn, help to improve health system strengthening at the National, Provincial and District levels through support to strengthen surveillance systems and monitoring tools and utilization of evidence collected from these systems to positively impact GOI programming and policies. PQM will support Indonesia to participate in ASEAN efforts to strengthen and harmonize pharmaceutical technical requirements for registration, GMP audits and bioavailability and bioequivalence testing. PQM will work closely with by JSI DELIVER, which provides complimentary support to the health care system through efficient shipment of essential medicines and prevention of stock-outs.
Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.
This mechanism has no published performance targets or indicators.
